Join us to support Clayton Baker’s fight against cancer.
At EY, we are a family, and it is in that spirit that we are reaching out. Clayton has been with EY for 12 years, during which time he led our Banking Performance Improvement (PI), overall PI competency teams and launched our successful Managed Services offerings. Clayton is currently undergoing treatment for sarcoma cancer and we would like to continue to support him and his family. We’ve set a goal to raise $45,000 for the Paula Takacs Foundation for Sarcoma Research in Clayton’s honor to fund a trial at Levine Cancer Institute utilizing liquid biopsy techniques for treatment response and disease surveillance in certain intermediate- and high-grade sarcoma patients. The Paula Takacs Foundation for Sarcoma Research is a nonprofit located in Charlotte, NC and partners locally with Atrium Health’s Levine Cancer Institute and Levine Children’s Hospital. A whopping 93% of all donations go towards funding clinical trials and research in pediatric and adult sarcomas. To date, the foundation has donated $1.4 million for sarcoma research.
WHAT IS THE PAULA TAKACS FOUNDATION FOR SARCOMA RESEARCH?
The Paula Takacs Foundation for Sarcoma Research is a 501(c)(3) nonprofit corporation that funds clinical trials and other research in pediatric and adult sarcomas. The foundation is located in Charlotte, NC and partners locally with Atrium Health’s Levine Cancer Institute and Levine Children’s. Recently the foundation funded an immunotherapy clinical trial that had such groundbreaking results that it was presented at the largest international oncology conference in the United States. We encourage you to read about all of the research being funded by this nonprofit and review their 2019 Form 990 and 2019 Annual Report. To date the foundation has donated $1.4 million for sarcoma research. In 2019 the expense ratio of the foundation was 7%, demonstrating their commitment to funding the development of sarcoma cures.
WHAT IS SARCOMA? WHY DONATE TO SARCOMA RESEARCH?
Sarcoma is a cancer of the bone or connective tissue, such as nerves, muscles, cartilage, tendons, fat, and blood vessels. There are over 150 subtypes of bone and soft tissue sarcomas. These malignancies can occur anywhere in the body. Some basic warning signs of sarcomas are unexplained swelling, lump, or pain in an arm, leg, or torso; fever; weight loss.
Sarcomas occur in people of all ages, but disproportionately diagnosed in children, adolescents and young adults. In fact, about 50% of all diagnoses are in people under the age of 35. Sarcomas are curable by surgery about 20% of the time, or by surgery with chemotherapy and/or radiation 30% of the time, yet today nearly half of the time they remain totally resistant to all of these approaches.
Since sarcomas are rare cancers, they receive very little research funding. As a result, the only first-line drug treatment that exists today for all 50+ soft tissue sarcomas was approved by the FDA in 1974! There is a critical need for private philanthropy to develop new sarcoma drugs.